Hybrid PET- and MR-driven attenuation correction for enhanced F-NaF and F-FDG quantification in cardiovascular PET/MR imaging.

TitleHybrid PET- and MR-driven attenuation correction for enhanced F-NaF and F-FDG quantification in cardiovascular PET/MR imaging.
Publication TypeJournal Article
Year of Publication2020
AuthorsKarakatsanis NA, Abgral R, Trivieri MGiovanna, Dweck MR, Robson PM, Calcagno C, Boeykens G, Senders ML, Mulder WJM, Tsoumpas C, Fayad ZA
JournalJ Nucl Cardiol
Volume27
Issue4
Pagination1126-1141
Date Published2020 08
ISSN1532-6551
KeywordsAdult, Animals, Bone and Bones, Carotid Artery Diseases, Female, Fluorodeoxyglucose F18, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multimodal Imaging, Positron Emission Tomography Computed Tomography, Rabbits, Radiopharmaceuticals, Sodium Fluoride
Abstract

BACKGROUND: The standard MR Dixon-based attenuation correction (AC) method in positron emission tomography/magnetic resonance (PET/MR) imaging segments only the air, lung, fat and soft-tissues (4-class), thus neglecting the highly attenuating bone tissues and affecting quantification in bones and adjacent vessels. We sought to address this limitation by utilizing the distinctively high bone uptake rate constant K expected from F-Sodium Fluoride (F-NaF) to segment bones from PET data and support 5-class hybrid PET/MR-driven AC for F-NaF and F-Fluorodeoxyglucose (F-FDG) PET/MR cardiovascular imaging.

METHODS: We introduce 5-class K/MR-AC for (i) F-NaF studies where the bones are segmented from Patlak K images and added as the 5th tissue class to the MR Dixon 4-class AC map. Furthermore, we propose two alternative dual-tracer protocols to permit 5-class K/MR-AC for (ii) F-FDG-only data, with a streamlined simultaneous administration of F-FDG and F-NaF at 4:1 ratio (R4:1), or (iii) for F-FDG-only or both F-FDG and F-NaF dual-tracer data, by administering F-NaF 90 minutes after an equal F-FDG dosage (R1:1). The K-driven bone segmentation was validated against computed tomography (CT)-based segmentation in rabbits, followed by PET/MR validation on 108 vertebral bone and carotid wall regions in 16 human volunteers with and without prior indication of carotid atherosclerosis disease (CAD).

RESULTS: In rabbits, we observed similar (< 1.2% mean difference) vertebral bone F-NaF SUV scores when applying 5-class AC with K-segmented bone (5-class K/CT-AC) vs CT-segmented bone (5-class CT-AC) tissue. Considering the PET data corrected with continuous CT-AC maps as gold-standard, the percentage SUV bias was reduced by 17.6% (F-NaF) and 15.4% (R4:1) with 5-class K/CT-AC vs 4-class CT-AC. In humans without prior CAD indication, we reported 17.7% and 20% higher F-NaF target-to-background ratio (TBR) at carotid bifurcations wall and vertebral bones, respectively, with 5- vs 4-class AC. In the R4:1 human cohort, the mean F-FDG:F-NaF TBR increased by 12.2% at carotid bifurcations wall and 19.9% at vertebral bones. For the R1:1 cohort of subjects without CAD indication, mean TBR increased by 15.3% (F-FDG) and 15.5% (F-NaF) at carotid bifurcations and 21.6% (F-FDG) and 22.5% (F-NaF) at vertebral bones. Similar TBR enhancements were observed when applying the proposed AC method to human subjects with prior CAD indication.

CONCLUSIONS: K-driven bone segmentation and 5-class hybrid PET/MR-driven AC is feasible and can significantly enhance F-NaF and F-FDG contrast and quantification in bone tissues and carotid walls.

DOI10.1007/s12350-019-01928-0
Alternate JournalJ Nucl Cardiol
PubMed ID31667675
PubMed Central IDPMC7190435
Grant ListFS/14/78/31020 / BHF_ / British Heart Foundation / United Kingdom
R01 HL071021 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065